News
Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...
2d
InvestorsHub on MSNTonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine ResultsTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that Dr. Sina Bavari, Executive Vice President of Infe ...
Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...
Market is projected to grow at a CAGR of 5% through 2029, fueled by rising R&D costs, declining pharmaceutical sales, growing ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biotech company, announced its inclusion in the Russell 3000® and Russell 2000® Indexes fol ...
Tonix Pharmaceuticals (NASDAQ:TNXP) announced on Monday an addition to the broad-market Russell 3000 Index and an automatic inclusion in the small-cap Russell 2000 Index. Shares were +0.32% pre-market ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company, today ...
Tonix Pharmaceuticals Holding Corp. detailed financials by Barron's. View TNXP business summary and company performance, for a clear financial breakdown.
Get the latest (TONIX) stock news and headlines to help you in your trading and investing decisions.
UCB’s Fintepla has been approved to treat seizures associated with two epilepsy disorders and now has posted data that could pave the way for its use in another epilepsy condition.
“Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock gained on optimism for the launch of its new drug Journavx, a non-opioid painkiller for acute pain and the first new class of pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results